Duke University Health System · 1 week ago
Investment Analyst, DUMAC
DUMAC, Inc. is the investment office managing a $27 billion portfolio on behalf of Duke University and its affiliates. The Investment Analyst role involves sourcing, evaluating, and monitoring investment opportunities while performing qualitative and quantitative analysis to support asset allocation decisions.
Health CareMedical
Responsibilities
Assist in the identification, evaluation, selection, and monitoring of investment opportunities
Perform qualitative and quantitative analysis to evaluate and compare opportunities, risks, and performance of current and potential investments
Assist in determining the appropriate asset allocation for DUMAC's portfolio
Help maintain the investments database
Directly assist the Chief Investment Officer and other investment team members in making critical presentations
Draft reports detailing investment recommendations and actions
Independently research projects related to portfolio management and new investment areas
Qualification
Required
Bachelor's degree from accredited college or university attained or expected by May 2026, with an excellent academic record
Excellent written and verbal communication skills
Strong analytical ability and research skills
Proficiency with quantitative tools
Strong time management skills and the ability to handle multiple projects and priorities
Ability to work with and contribute to a small, dynamic team
High personal integrity and absolute discretion in handling confidential business information
Ability to interact with business executives and appropriately represent DUMAC in business social situations
Strong interest in investing, for example, through internships, projects, prior work experience, or personal investing
Benefits
DUMAC also provides full financial support for analysts pursuing the Chartered Financial Analyst (CFA) exams.
Company
Duke University Health System
World-class academic and health care system
Funding
Current Stage
Late StageLeadership Team
Recent News
The Philadelphia Inquirer
2025-11-27
2025-10-09
2025-10-02
Company data provided by crunchbase